(Q35113300)

6 August 2017

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy (English)

1 reference

6 August 2017

anti-retroviral agent

0 references

Oliver Hofmann

4

0 references

Winston Hide

object named as

Winston Hide

15

0 references

Babafemi Taiwo

11

object named as

Babafemi Taiwo

1 reference

6 August 2017

10

Joseph Eron

1 reference

6 August 2017

2

Brad Chapman

1 reference

6 August 2017

14

Daniel R Kuritzkes

1 reference

6 August 2017

Jonathan Z Li

1

1 reference

6 August 2017

Patrick Charlebois

3

1 reference

6 August 2017

Brian Weiner

5

1 reference

6 August 2017

Alyssa J Porter

6

1 reference

6 August 2017

Reshmi Samuel

7

1 reference

6 August 2017

Saran Vardhanabhuti

8

1 reference

6 August 2017

Lu Zheng

9

1 reference

6 August 2017

Michael C Zody

12

1 reference

6 August 2017

Matthew R Henn

13

1 reference

6 August 2017

ACTG A5262 Study Team

16

1 reference

6 August 2017

Cara C Wilson

17

1 reference

6 August 2017

Baiba I Berzins

18

1 reference

6 August 2017

Edward P Acosta

19

1 reference

6 August 2017

Barbara Bastow

20

1 reference

6 August 2017

Peter S Kim

21

1 reference

6 August 2017

Sarah W Read

22

1 reference

6 August 2017

Jennifer Janik

23

1 reference

6 August 2017

Debra S Meres

24

1 reference

6 August 2017

Michael M Lederman

25

1 reference

6 August 2017

Lori Mong-Kryspin

26

1 reference

6 August 2017

Karl E Shaw

27

1 reference

6 August 2017

Louis G Zimmerman

28

1 reference

6 August 2017

Randi Leavitt

29

1 reference

6 August 2017

Guy De La Rosa

30

1 reference

6 August 2017

Amy Jennings

31

1 reference

6 August 2017

language of work or name

English

0 references

publication date

6 March 2014

1 reference

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

3

1 reference

6 August 2017

e90485

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

6 March 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Prize-based contests can provide solutions to computational biology problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Read length versus depth of coverage for viral quasispecies reconstruction

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Direct comparisons of Illumina vs. Roche 454 sequencing technologies on the same microbial community DNA sample

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Switching between raltegravir resistance pathways analyzed by deep sequencing

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

HIV-1 integrase inhibitor resistance and its clinical implications

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946168

Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing.

9 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090485

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090485

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090485

10.1371/JOURNAL.PONE.0090485

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference